{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:41:38Z","timestamp":1771634498116,"version":"3.50.1"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2008,5,6]],"date-time":"2008-05-06T00:00:00Z","timestamp":1210032000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1038\/ncpuro1124","type":"journal-article","created":{"date-parts":[[2008,5,6]],"date-time":"2008-05-06T13:57:14Z","timestamp":1210082234000},"page":"319-328","source":"Crossref","is-referenced-by-count":107,"title":["Drug Insight: biological effects of botulinum toxin A in the lower urinary tract"],"prefix":"10.1038","volume":"5","author":[{"given":"Michael B","family":"Chancellor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clare J","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apostolos","family":"Apostolidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William C","family":"de Groat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher P","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George T","family":"Somogyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Roger Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,5,6]]},"reference":[{"key":"BFncpuro1124_CR1","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/mus.10213","volume":"26","author":"CR Billante","year":"2002","unstructured":"Billante CR et al. (2002) Comparison of neuromuscular blockade and recovery with botulinum toxins A and F. Muscle Nerve 26: 395\u2013403","journal-title":"Muscle Nerve"},{"key":"BFncpuro1124_CR2","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0041-0101(01)00082-4","volume":"39","author":"CV Jurasinski","year":"2001","unstructured":"Jurasinski CV et al. (2001) Correlation of cleavage of SNAP-25 with muscle function in a rat model of Botulinum neurotoxin type A induced paralysis. Toxicon 39: 1309\u20131315","journal-title":"Toxicon"},{"key":"BFncpuro1124_CR3","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/jor.20131","volume":"24","author":"J Shen","year":"2006","unstructured":"Shen J et al. (2006) How muscles recover from paresis and atrophy after intramuscular injection of botulinum toxin A: study in juvenile rats. J Orthop Res 24: 1128\u20131135","journal-title":"J Orthop Res"},{"key":"BFncpuro1124_CR4","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.ju.0000162035.73977.1c","volume":"174","author":"B Schurch","year":"2005","unstructured":"Schurch B et al. (2005) Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol 174: 196\u2013200","journal-title":"J Urol"},{"key":"BFncpuro1124_CR5","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/clinids\/1.4.656","volume":"1","author":"LL Simpson","year":"1979","unstructured":"Simpson LL (1979) The action of botulinal toxin. Rev Infect Dis 1: 656\u2013662","journal-title":"Rev Infect Dis"},{"key":"BFncpuro1124_CR6","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/2338","volume":"5","author":"DB Lacy","year":"1998","unstructured":"Lacy DB et al. (1998) Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat Struct Biol 5: 898\u2013902","journal-title":"Nat Struct Biol"},{"issue":"Suppl 5","key":"BFncpuro1124_CR7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1468-1331.2001.00035.x","volume":"8","author":"KR Aoki","year":"2001","unstructured":"Aoki KR and Guyer B (2001) Botulinum toxin type A and other botulinum toxin serotypes: a comparative review of biochemical and pharmacological actions. Eur J Neurol 8 (Suppl 5): 21\u201329","journal-title":"Eur J Neurol"},{"key":"BFncpuro1124_CR8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.pharmtox.44.101802.121554","volume":"44","author":"LL Simpson","year":"2004","unstructured":"Simpson LL (2004) Identification of the major steps in botulinum toxin action. Annu Rev Pharmacol Toxicol 44: 167\u2013193","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"BFncpuro1124_CR9","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1128\/IAI.57.9.2634-2639.1989","volume":"57","author":"S Kozaki","year":"1989","unstructured":"Kozaki S et al. (1989) Immunological characterization of papain-induced fragments of Clostridium botulinum type A neurotoxin and interaction of the fragments with brain synaptosomes. Infect Immun 57: 2634\u20132639","journal-title":"Infect Immun"},{"key":"BFncpuro1124_CR10","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.2174\/0929867043363802","volume":"11","author":"KR Aoki","year":"2004","unstructured":"Aoki KR (2004) Botulinum toxin: a successful therapeutic protein. Curr Med Chem 11: 3085\u20133092","journal-title":"Curr Med Chem"},{"key":"BFncpuro1124_CR11","doi-asserted-by":"crossref","first-page":"6888","DOI":"10.1073\/pnas.0400584101","volume":"101","author":"B Segelke","year":"2004","unstructured":"Segelke B et al. (2004) Crystal structure of Clostridium botulinum neurotoxin protease in a product-bound state: evidence for noncanonical zinc protease activity. Proc Natl Acad Sci U S A 101: 6888\u20136893","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFncpuro1124_CR12","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1016\/S0021-9258(18)61557-1","volume":"262","author":"S Bandyopadhyay","year":"1987","unstructured":"Bandyopadhyay S et al. (1987) Role of the heavy and light chains of botulinum neurotoxin in neuromuscular paralysis. J Biol Chem 262: 2660\u20132663","journal-title":"J Biol Chem"},{"key":"BFncpuro1124_CR13","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1083\/jcb.103.2.535","volume":"103","author":"JD Black","year":"1986","unstructured":"Black JD and Dolly JO (1986) Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. II. Autoradiographic evidence for its uptake into motor nerves by acceptor-mediated endocytosis. J Cell Biol 103: 535\u2013544","journal-title":"J Cell Biol"},{"key":"BFncpuro1124_CR14","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/307457a0","volume":"307","author":"JO Dolly","year":"1984","unstructured":"Dolly JO et al. (1984) Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalization. Nature 307: 457\u2013460","journal-title":"Nature"},{"key":"BFncpuro1124_CR15","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/0306-4522(87)90094-7","volume":"23","author":"JD Black","year":"1987","unstructured":"Black JD and Dolly JO (1987) Selective location of acceptors for botulinum neurotoxin A in the central and peripheral nervous systems. Neuroscience 23: 767\u2013779","journal-title":"Neuroscience"},{"key":"BFncpuro1124_CR16","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1432-1033.1983.tb07282.x","volume":"131","author":"RS Williams","year":"1983","unstructured":"Williams RS et al. (1983) Radioiodination of botulinum neurotoxin type A with retention of biological activity and its binding to brain synaptosomes. Eur J Biochem 131: 437\u2013445","journal-title":"Eur J Biochem"},{"key":"BFncpuro1124_CR17","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1123654","volume":"312","author":"M Dong","year":"2006","unstructured":"Dong M et al. (2006) SV2 is the protein receptor for botulinum neurotoxin A. Science 312: 592\u2013596","journal-title":"Science"},{"key":"BFncpuro1124_CR18","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/j.febslet.2006.02.074","volume":"580","author":"S Mahrhold","year":"2006","unstructured":"Mahrhold S et al. (2006) The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves. FEBS Lett 580: 2011\u20132014","journal-title":"FEBS Lett"},{"key":"BFncpuro1124_CR19","doi-asserted-by":"crossref","first-page":"13476","DOI":"10.1074\/jbc.M010992200","volume":"276","author":"JE Keller","year":"2001","unstructured":"Keller JE and Neale EA (2001) The role of the synaptic protein SNAP-25 in the potency of botulinum neurotoxin type A. J Biol Chem 276: 13476\u201313482","journal-title":"J Biol Chem"},{"key":"BFncpuro1124_CR20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0014-5793(87)80562-8","volume":"226","author":"RO Blaustein","year":"1987","unstructured":"Blaustein RO et al. (1987) The N-terminal half of the heavy chain of botulinum type A neurotoxin forms channels in planar phospholipid bilayers. FEBS Lett 226: 115\u2013120","journal-title":"FEBS Lett"},{"key":"BFncpuro1124_CR21","doi-asserted-by":"crossref","first-page":"6466","DOI":"10.1021\/bi992729u","volume":"39","author":"L Li","year":"2000","unstructured":"Li L and Singh BR (2000) Spectroscopic analysis of pH-induced changes in the molecular features of type A botulinum neurotoxin light chain. Biochemistry 39: 6466\u20136474","journal-title":"Biochemistry"},{"key":"BFncpuro1124_CR22","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/0014-5793(94)00449-8","volume":"346","author":"C Montecucco","year":"1994","unstructured":"Montecucco C et al. (1994) Bacterial protein toxins penetrate cells via a four-step mechanism. FEBS Lett 346: 92\u201398","journal-title":"FEBS Lett"},{"key":"BFncpuro1124_CR23","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S0022-3565(24)38842-1","volume":"296","author":"S Kalandakanond","year":"2001","unstructured":"Kalandakanond S and Coffield JA (2001) Cleavage of SNAP-25 by botulinum toxin type A requires receptor-mediated endocytosis, pH-dependent translocation, and zinc. J Pharmacol Exp Ther 296: 980\u2013986","journal-title":"J Pharmacol Exp Ther"},{"key":"BFncpuro1124_CR24","first-page":"180","volume":"84","author":"G Schiavo","year":"1990","unstructured":"Schiavo G et al. (1990) Membrane interactions of tetanus and botulinum neurotoxins: a photolabelling study with photoactivatable phospholipids. J Physiol (Paris) 84: 180\u2013187","journal-title":"J Physiol (Paris)"},{"key":"BFncpuro1124_CR25","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/364827a0","volume":"364","author":"MF Schmid","year":"1993","unstructured":"Schmid MF et al. (1993) Direct visualization of botulinum neurotoxin-induced channels in phospholipid vesicles. Nature 364: 827\u2013830","journal-title":"Nature"},{"key":"BFncpuro1124_CR26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nsb879","volume":"10","author":"LK Koriazova","year":"2003","unstructured":"Koriazova LK and Montal M (2003) Translocation of botulinum neurotoxin light chain protease through the heavy chain channel. Nat Struct Biol 10: 13\u201318","journal-title":"Nat Struct Biol"},{"key":"BFncpuro1124_CR27","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1073\/pnas.82.6.1692","volume":"82","author":"DH Hoch","year":"1985","unstructured":"Hoch DH et al. (1985) Channels formed by botulinum, tetanus, and diphtheria toxins in planar lipid bilayers: relevance to translocation of proteins across membranes. Proc Natl Acad Sci U S A 82: 1692\u20131696","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFncpuro1124_CR28","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0041-0101(97)00131-1","volume":"36","author":"RE Sheridan","year":"1998","unstructured":"Sheridan RE (1998) Gating and permeability of ion channels produced by botulinum toxin types A and E in PC12 cell membranes. Toxicon 36: 703\u2013717","journal-title":"Toxicon"},{"key":"BFncpuro1124_CR29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0301-4622(02)00135-7","volume":"99","author":"FN Fu","year":"2002","unstructured":"Fu FN et al. (2002) Spectroscopic analysis of low pH and lipid-induced structural changes in type A botulinum neurotoxin relevant to membrane channel formation and translocation. Biophys Chem 99: 17\u201329","journal-title":"Biophys Chem"},{"key":"BFncpuro1124_CR30","first-page":"720","volume":"267","author":"LL Simpson","year":"1993","unstructured":"Simpson LL et al. (1993) Chelation of zinc antagonizes the neuromuscular blocking properties of the seven serotypes of botulinum neurotoxin as well as tetanus toxin. J Pharmacol Exp Ther 267: 720\u2013727","journal-title":"J Pharmacol Exp Ther"},{"key":"BFncpuro1124_CR31","doi-asserted-by":"crossref","first-page":"27034","DOI":"10.1074\/jbc.M102172200","volume":"276","author":"LL Simpson","year":"2001","unstructured":"Simpson LL et al. (2001) The role of zinc binding in the biological activity of botulinum toxin. J Biol Chem 276: 27034\u201327041","journal-title":"J Biol Chem"},{"key":"BFncpuro1124_CR32","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1097\/01.ju.0000127725.48479.89","volume":"171","author":"CP Smith","year":"2004","unstructured":"Smith CP and Chancellor MB (2004) Emerging role of botulinum toxin in the management of voiding dysfunction. J Urol 171: 2128\u20132137","journal-title":"J Urol"},{"key":"BFncpuro1124_CR33","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/0959-4388(94)90002-7","volume":"4","author":"TF Martin","year":"1994","unstructured":"Martin TF (1994) The molecular machinery for fast and slow neurosecretion. Curr Opin Neurobiol 4: 626\u2013632","journal-title":"Curr Opin Neurobiol"},{"key":"BFncpuro1124_CR34","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1749-6632.1994.tb26614.x","volume":"710","author":"G Schiavo","year":"1994","unstructured":"Schiavo G et al. (1994) Tetanus and botulinum neurotoxins are zinc proteases specific for components of the neuroexocytosis apparatus. Ann N Y Acad Sci 710: 65\u201375","journal-title":"Ann N Y Acad Sci"},{"key":"BFncpuro1124_CR35","doi-asserted-by":"crossref","first-page":"10354","DOI":"10.1016\/S0021-9258(18)81627-1","volume":"264","author":"MA Bittner","year":"1989","unstructured":"Bittner MA et al. (1989) Isolated light chains of botulinum neurotoxins inhibit exocytosis. Studies in digitonin-permeabilized chromaffin cells. J Biol Chem 264: 10354\u201310360","journal-title":"J Biol Chem"},{"key":"BFncpuro1124_CR36","first-page":"91","volume-title":"Scientific and Therapeutic Aspects of Botulinum Toxin","author":"JO Dolly","year":"2002","unstructured":"Dolly JO et al. (2002) Insights into the extended duration of neuroparalysis by botulinum neurotoxin A relative to the other shorter-acting serotypes: differences between motor nerve terminals and cultured neurons. In Scientific and Therapeutic Aspects of Botulinum Toxin, 91\u2013102 (Eds Brin MF et al.) Philadelphia: Lippincott Williams & Wilkins"},{"key":"BFncpuro1124_CR37","doi-asserted-by":"crossref","first-page":"36897","DOI":"10.1074\/jbc.274.52.36897","volume":"274","author":"GA O'Sullivan","year":"1999","unstructured":"O'Sullivan GA et al. (1999) Rescue of exocytosis in botulinum toxin A-poisoned chromaffin cells by expression of cleavage-resistant SNAP-25. Identification of the minimal essential C-terminal residues. J Biol Chem 274: 36897\u201336904","journal-title":"J Biol Chem"},{"key":"BFncpuro1124_CR38","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0968-0004(02)02177-1","volume":"27","author":"K Turton","year":"2002","unstructured":"Turton K et al. (2002) Botulinum and tetanus neurotoxins: structure, function and therapeutic utility. Trends Biochem Sci 27: 552\u2013558","journal-title":"Trends Biochem Sci"},{"key":"BFncpuro1124_CR39","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1073\/pnas.0400229101","volume":"101","author":"E Fernandez-Salas","year":"2004","unstructured":"Fernandez-Salas E et al. (2004) Plasma membrane localization signals in the light chain of botulinum neurotoxin. Proc Natl Acad Sci U S A 101: 3208\u20133213","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFncpuro1124_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-5793(97)01328-8","volume":"418","author":"P Washbourne","year":"1997","unstructured":"Washbourne P et al. (1997) Botulinum neurotoxin types A and E require the SNARE motif in SNAP-25 for proteolysis. FEBS Lett 418: 1\u20135","journal-title":"FEBS Lett"},{"key":"BFncpuro1124_CR41","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.molmed.2005.06.012","volume":"11","author":"MA Breidenbach","year":"2005","unstructured":"Breidenbach MA and Brunger AT (2005) New insights into clostridial neurotoxin-SNARE interactions. Trends Mol Med 11: 377\u2013381","journal-title":"Trends Mol Med"},{"key":"BFncpuro1124_CR42","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1074\/jbc.M209821200","volume":"278","author":"PG Foran","year":"2003","unstructured":"Foran PG et al. (2003) Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons. J Biol Chem 278: 1363\u20131371","journal-title":"J Biol Chem"},{"key":"BFncpuro1124_CR43","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S1044-7431(02)00016-7","volume":"22","author":"FA Meunier","year":"2003","unstructured":"Meunier FA et al. (2003) Dynamics of motor nerve terminal remodeling unveiled using SNARE-cleaving botulinum toxins: the extent and duration are dictated by the sites of SNAP-25 truncation. Mol Cell Neurosci 22: 454\u2013466","journal-title":"Mol Cell Neurosci"},{"key":"BFncpuro1124_CR44","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0304-3940(98)00775-7","volume":"256","author":"R Eleopra","year":"1998","unstructured":"Eleopra R et al. (1998) Different time courses of recovery after poisoning with botulinum neurotoxin serotypes A and E in humans. Neurosci Lett 256: 135\u2013138","journal-title":"Neurosci Lett"},{"key":"BFncpuro1124_CR45","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1212\/WNL.49.1.189","volume":"49","author":"RR Sloop","year":"1997","unstructured":"Sloop RR et al. (1997) Human response to botulinum toxin injection: type B compared with type A. Neurology 49: 189\u2013194","journal-title":"Neurology"},{"key":"BFncpuro1124_CR46","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0014-5793(99)00948-5","volume":"456","author":"JE Keller","year":"1999","unstructured":"Keller JE et al. (1999) Persistence of botulinum neurotoxin action in cultured spinal cord cells. FEBS Lett 456: 137\u2013142","journal-title":"FEBS Lett"},{"key":"BFncpuro1124_CR47","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3109\/00016489309135834","volume":"113","author":"GM Filippi","year":"1993","unstructured":"Filippi GM et al. (1993) Botulinum A toxin effects on rat jaw muscle spindles. Acta Otolaryngol 113: 400\u2013404","journal-title":"Acta Otolaryngol"},{"key":"BFncpuro1124_CR48","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/(SICI)1097-4598(199604)19:4<488::AID-MUS9>3.0.CO;2-8","volume":"19","author":"RL Rosales","year":"1996","unstructured":"Rosales RL et al. (1996) Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection. Muscle Nerve 19: 488\u2013496","journal-title":"Muscle Nerve"},{"key":"BFncpuro1124_CR49","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/(SICI)1097-4598(199812)21:12<1701::AID-MUS12>3.0.CO;2-K","volume":"21","author":"N Modugno","year":"1998","unstructured":"Modugno N et al. (1998) Botulinum toxin restores presynaptic inhibition of group Ia afferents in patients with essential tremor. Muscle Nerve 21: 1701\u20131705","journal-title":"Muscle Nerve"},{"key":"BFncpuro1124_CR50","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/01658109209058127","volume":"12","author":"GE Borodic","year":"1992","unstructured":"Borodic GE and Ferrante R (1992) Effects of repeated botulinum toxin injections on orbicularis oculi muscle. J Clin Neuroophthalmol 12: 121\u2013127","journal-title":"J Clin Neuroophthalmol"},{"key":"BFncpuro1124_CR51","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1001\/archopht.1987.01060120101035","volume":"105","author":"RF Spencer","year":"1987","unstructured":"Spencer RF and McNeer KW (1987) Botulinum toxin paralysis of adult monkey extraocular muscle. Structural alterations in orbital, singly innervated muscle fibers. Arch Ophthalmol 105: 1703\u20131711","journal-title":"Arch Ophthalmol"},{"key":"BFncpuro1124_CR52","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1001\/archopht.1991.01080030095046","volume":"109","author":"CP Harris","year":"1991","unstructured":"Harris CP et al. (1991) Histologic features of human orbicularis oculi treated with botulinum A toxin. Arch Ophthalmol 109: 393\u2013395","journal-title":"Arch Ophthalmol"},{"key":"BFncpuro1124_CR53","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00006534-199102000-00010","volume":"87","author":"GE Borodic","year":"1991","unstructured":"Borodic GE et al. (1991) Botulinum A toxin for the treatment of adult-onset spasmodic torticollis. Plast Reconstr Surg 87: 285\u2013289","journal-title":"Plast Reconstr Surg"},{"key":"BFncpuro1124_CR54","first-page":"167","volume":"84","author":"S Thesleff","year":"1990","unstructured":"Thesleff S et al. (1990) Trophic interrelations at the neuromuscular junction as revealed by the use of botulinal neurotoxins. J Physiol (Paris) 84: 167\u2013173","journal-title":"J Physiol (Paris)"},{"key":"BFncpuro1124_CR55","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1073\/pnas.96.6.3200","volume":"96","author":"A de Paiva","year":"1999","unstructured":"de Paiva A et al. (1999) Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci U S A 96: 3200\u20133205","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFncpuro1124_CR56","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1212\/WNL.41.11.1800","volume":"41","author":"K Alderson","year":"1991","unstructured":"Alderson K et al. (1991) Botulinum-induced alteration of nerve-muscle interactions in the human orbicularis oculi following treatment for blepharospasm. Neurology 41: 1800\u20131805","journal-title":"Neurology"},{"key":"BFncpuro1124_CR57","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0960-8966(96)00041-7","volume":"6","author":"P Juzans","year":"1996","unstructured":"Juzans P et al. (1996) Nerve terminal sprouting in botulinum type-A treated mouse levator auris longus muscle. Neuromuscul Disord 6: 177\u2013185","journal-title":"Neuromuscul Disord"},{"key":"BFncpuro1124_CR58","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0306-4522(90)90109-H","volume":"37","author":"D Angaut-Petit","year":"1990","unstructured":"Angaut-Petit D et al. (1990) Terminal sprouting in mouse neuromuscular junctions poisoned with botulinum type A toxin: morphological and electrophysiological features. Neuroscience 37: 799\u2013808","journal-title":"Neuroscience"},{"key":"BFncpuro1124_CR59","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/mus.10274","volume":"26","author":"MJ Van Putten","year":"2002","unstructured":"Van Putten MJ et al. (2002) In vivo analysis of end-plate noise of human extensor digitorum brevis muscle after intramuscularly injected botulinum toxin type A. Muscle Nerve 26: 784\u2013790","journal-title":"Muscle Nerve"},{"key":"BFncpuro1124_CR60","unstructured":"Chancellor MB et al. (2003) Successful use of bladder botulinum toxin injection to treat refractory overactive bladder [abstract DP50]. 98th Annual Meeting of the American Urological Association, Chicago, IL, USA"},{"key":"BFncpuro1124_CR61","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/01.ju.0000169480.43557.31","volume":"174","author":"R Popat","year":"2005","unstructured":"Popat R et al. (2005) A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin. J Urol 174: 984\u2013989","journal-title":"J Urol"},{"key":"BFncpuro1124_CR62","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.urology.2004.08.016","volume":"65","author":"CP Smith","year":"2005","unstructured":"Smith CP et al. (2005) Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra. Urology 65: 37\u201341","journal-title":"Urology"},{"key":"BFncpuro1124_CR63","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1097\/01.ju.0000049202.56189.54","volume":"169","author":"CP Smith","year":"2003","unstructured":"Smith CP et al. (2003) Effect of botulinum toxin A on the autonomic nervous system of the rat lower urinary tract. J Urol 169: 1896\u20131900","journal-title":"J Urol"},{"issue":"Pt 1","key":"BFncpuro1124_CR64","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1113\/jphysiol.1996.sp021681","volume":"496","author":"GT Somogyi","year":"1996","unstructured":"Somogyi GT et al. (1996) M1 muscarinic receptor-induced facilitation of ACh and noradrenaline release in the rat bladder is mediated by protein kinase C. J Physiol 496 (Pt 1): 245\u2013254","journal-title":"J Physiol"},{"key":"BFncpuro1124_CR65","first-page":"3","volume":"119","author":"FM Chu","year":"2006","unstructured":"Chu FM and Dmochowski R (2006) Pathophysiology of overactive bladder. Am J Med 119: 3\u20138","journal-title":"Am J Med"},{"key":"BFncpuro1124_CR66","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/sj.bjp.0702041","volume":"125","author":"GT Somogyi","year":"1998","unstructured":"Somogyi GT et al. (1998) Frequency dependence of muscarinic facilitation of transmitter release in urinary bladder strips from neurally intact or chronic spinal cord transected rats. Br J Pharmacol 125: 241\u2013246","journal-title":"Br J Pharmacol"},{"key":"BFncpuro1124_CR67","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0022-5347(05)68247-X","volume":"162","author":"M Bayliss","year":"1999","unstructured":"Bayliss M et al. (1999) A quantitative study of atropine-resistant contractile responses in human detrusor smooth muscle, from stable, unstable and obstructed bladders. J Urol 162: 1833\u20131839","journal-title":"J Urol"},{"key":"BFncpuro1124_CR68","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0022-5347(05)65403-1","volume":"167","author":"BA O'Reilly","year":"2002","unstructured":"O'Reilly BA et al. (2002) P2X receptors and their role in female idiopathic detrusor instability. J Urol 167: 157\u2013164","journal-title":"J Urol"},{"key":"BFncpuro1124_CR69","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.urology.2005.06.099","volume":"66","author":"J Nishiguchi","year":"2005","unstructured":"Nishiguchi J et al. (2005) Detrusor overactivity induced by intravesical application of adenosine 5\u2032-triphosphate under different delivery conditions in rats. Urology 66: 1332\u20131337","journal-title":"Urology"},{"key":"BFncpuro1124_CR70","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/0306-4522(82)90056-2","volume":"7","author":"I MacKenzie","year":"1982","unstructured":"MacKenzie I et al. (1982) The effects of purified botulinum neurotoxin type A on cholinergic, adrenergic and non-adrenergic, atropine-resistant autonomic neuromuscular transmission. Neuroscience 7: 997\u20131006","journal-title":"Neuroscience"},{"key":"BFncpuro1124_CR71","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0361-9230(03)00114-X","volume":"61","author":"CP Smith","year":"2003","unstructured":"Smith CP et al. (2003) Effect of stimulation intensity and botulinum toxin isoform on rat bladder strip contractions. Brain Res Bull 61: 165\u2013171","journal-title":"Brain Res Bull"},{"key":"BFncpuro1124_CR72","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.eururo.2005.12.010","volume":"49","author":"A Apostolidis","year":"2006","unstructured":"Apostolidis A et al. (2006) Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity. Eur Urol 49: 644\u2013650","journal-title":"Eur Urol"},{"key":"BFncpuro1124_CR73","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1152\/physrev.00038.2003","volume":"84","author":"KE Andersson","year":"2004","unstructured":"Andersson KE and Arner A (2004) Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiol Rev 84: 935\u2013986","journal-title":"Physiol Rev"},{"key":"BFncpuro1124_CR74","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.neuint.2004.06.001","volume":"45","author":"M Khera","year":"2004","unstructured":"Khera M et al. (2004) Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury. Neurochem Int 45: 987\u2013993","journal-title":"Neurochem Int"},{"issue":"Suppl 2","key":"BFncpuro1124_CR75","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1038\/sj.bjp.0706637","volume":"147","author":"AP Ford","year":"2006","unstructured":"Ford AP et al. (2006) Purinoceptors as therapeutic targets for lower urinary tract dysfunction. Br J Pharmacol 147 (Suppl 2): S132\u2013S143","journal-title":"Br J Pharmacol"},{"key":"BFncpuro1124_CR76","doi-asserted-by":"crossref","first-page":"21077","DOI":"10.1074\/jbc.M101465200","volume":"276","author":"M Paukert","year":"2001","unstructured":"Paukert M et al. (2001) Inflammatory mediators potentiate ATP-gated channels through the P2X(3) subunit. J Biol Chem 276: 21077\u201321082","journal-title":"J Biol Chem"},{"key":"BFncpuro1124_CR77","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1111\/j.1432-1033.2004.04082.x","volume":"271","author":"DN Cortright","year":"2004","unstructured":"Cortright DN and Szallasi A (2004) Biochemical pharmacology of the vanilloid receptor TRPV1. An update. Eur J Biochem 271: 1814\u20131819","journal-title":"Eur J Biochem"},{"key":"BFncpuro1124_CR78","doi-asserted-by":"crossref","first-page":"25665","DOI":"10.1074\/jbc.M311515200","volume":"279","author":"C Morenilla-Palao","year":"2004","unstructured":"Morenilla-Palao C et al. (2004) Regulated exocytosis contributes to protein kinase C potentiation of vanilloid receptor activity. J Biol Chem 279: 25665\u201325672","journal-title":"J Biol Chem"},{"key":"BFncpuro1124_CR79","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/35012076","volume":"405","author":"JB Davis","year":"2000","unstructured":"Davis JB et al. (2000) Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature 405: 183\u2013187","journal-title":"Nature"},{"key":"BFncpuro1124_CR80","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.juro.2006.11.046","volume":"177","author":"A Charrua","year":"2007","unstructured":"Charrua A et al. (2007) Transient receptor potential vanilloid subfamily 1 is essential for the generation of noxious bladder input and bladder overactivity in cystitis. J Urol 177: 1537\u20131541","journal-title":"J Urol"},{"key":"BFncpuro1124_CR81","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/01.ju.0000169481.42259.54","volume":"174","author":"A Apostolidis","year":"2005","unstructured":"Apostolidis A et al. (2005) Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. J Urol 174: 977\u2013982","journal-title":"J Urol"},{"key":"BFncpuro1124_CR82","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/j.1464-410X.2007.07137.x","volume":"100","author":"H Schulte-Baukloh","year":"2007","unstructured":"Schulte-Baukloh H et al. (2007) Persistence of the synaptosomal-associated protein-25 cleavage product after intradetrusor botulinum toxin A injections in patients with myelomeningocele showing an inadequate response to treatment. BJU Int 100: 1075\u20131080","journal-title":"BJU Int"},{"key":"BFncpuro1124_CR83","first-page":"472","volume-title":"Principles of Neural Science","author":"AI Basbaum","year":"2000","unstructured":"Basbaum AI and Jessell TM (2000) The perception of pain. In Principles of Neural Science, edn 4, 472\u2013491 (Eds Kandel ER et al.) New York: McGraw Hill"},{"key":"BFncpuro1124_CR84","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuro.2005.01.017","volume":"26","author":"KR Aoki","year":"2005","unstructured":"Aoki KR (2005) Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology 26: 785\u2013793","journal-title":"Neurotoxicology"},{"key":"BFncpuro1124_CR85","first-page":"195","volume":"34","author":"M Zubrzycka","year":"2000","unstructured":"Zubrzycka M and Janecka A (2000) Substance P: transmitter of nociception (Minireview). Endocr Regul 34: 195\u2013201","journal-title":"Endocr Regul"},{"key":"BFncpuro1124_CR86","first-page":"37","volume":"77","author":"PJ Smet","year":"1997","unstructured":"Smet PJ et al. (1997) Distribution and colocalization of calcitonin gene-related peptide, tachykinins, and vasoactive intestinal peptide in normal and idiopathic unstable human urinary bladder. Lab Invest 77: 37\u201349","journal-title":"Lab Invest"},{"key":"BFncpuro1124_CR87","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1097\/01.ju.0000137844.77524.97","volume":"172","author":"YC Chuang","year":"2004","unstructured":"Chuang YC et al. (2004) Intravesical botulinum toxin A administration produces analgesia against acetic acid induced bladder pain responses in rats. J Urol 172: 1529\u20131532","journal-title":"J Urol"},{"key":"BFncpuro1124_CR88","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S0022-5347(05)00322-8","volume":"175","author":"DE Rapp","year":"2006","unstructured":"Rapp DE et al. (2006) Botulinum toxin type A inhibits calcitonin gene-related peptide release from isolated rat bladder. J Urol 175: 1138\u20131142","journal-title":"J Urol"},{"key":"BFncpuro1124_CR89","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/ncpuro0408","volume":"3","author":"WD Steers","year":"2006","unstructured":"Steers WD and Tuttle JB (2006) Mechanisms of Disease: the role of nerve growth factor in the pathophysiology of bladder disorders. Nat Clin Pract Urol 3: 101\u2013110","journal-title":"Nat Clin Pract Urol"},{"key":"BFncpuro1124_CR90","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1016\/S0022-5347(06)00258-8","volume":"175","author":"A Giannantoni","year":"2006","unstructured":"Giannantoni A et al. (2006) Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity. J Urol 175: 2341\u20132344","journal-title":"J Urol"},{"key":"BFncpuro1124_CR91","first-page":"P77","volume":"20","author":"M Relja","year":"2005","unstructured":"Relja M and Telarovic S (2005) Botulinum toxin type-A and pain responsiveness in cervical dystonia: a dose response study. Mov Disord 20: P77","journal-title":"Mov Disord"},{"key":"BFncpuro1124_CR92","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1517\/13543784.13.11.1437","volume":"13","author":"KA Foster","year":"2004","unstructured":"Foster KA (2004) The analgesic potential of clostridial neurotoxin derivatives. Expert Opin Investig Drugs 13: 1437\u20131443","journal-title":"Expert Opin Investig Drugs"},{"key":"BFncpuro1124_CR93","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/1531-8257(199911)14:6<1043::AID-MDS1026>3.0.CO;2-3","volume":"14","author":"D Tarsy","year":"1999","unstructured":"Tarsy D and First ER (1999) Painful cervical dystonia: clinical features and response to treatment with botulinum toxin. Mov Disord 14: 1043\u20131045","journal-title":"Mov Disord"},{"key":"BFncpuro1124_CR94","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2004.07.011","volume":"46","author":"A Haferkamp","year":"2004","unstructured":"Haferkamp A et al. (2004) Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type A in overactive neurogenic bladder. Eur Urol 46: 784\u2013791","journal-title":"Eur Urol"},{"key":"BFncpuro1124_CR95","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.eururo.2006.01.025","volume":"50","author":"E Comperat","year":"2006","unstructured":"Comperat E et al. (2006) Histologic features in the urinary bladder wall affected from neurogenic overactivity\u2014a comparison of inflammation, oedema and fibrosis with and without injection of botulinum toxin type A. Eur Urol 50: 1058\u20131064","journal-title":"Eur Urol"},{"key":"BFncpuro1124_CR96","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/mds.20376","volume":"20","author":"NI Mejia","year":"2005","unstructured":"Mejia NI et al. (2005) Long-term botulinum toxin efficacy, safety, and immunogenicity. Mov Disord 20: 592\u2013597","journal-title":"Mov Disord"}],"container-title":["Nature Clinical Practice Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpuro1124","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpuro1124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpuro1124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T03:05:38Z","timestamp":1738206338000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpuro1124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,6]]},"references-count":96,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["BFncpuro1124"],"URL":"https:\/\/doi.org\/10.1038\/ncpuro1124","relation":{},"ISSN":["1743-4270","1743-4289"],"issn-type":[{"value":"1743-4270","type":"print"},{"value":"1743-4289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,6]]}}}